Toggle light / dark theme

Statins Used to Lower Cholesterol Linked to Doubled Risk of Developing Dementia

If concerned, speak to your physician.


In patients with mild cognitive impairment, taking lipophilic statins more than doubles their risk of developing dementia compared to those who do not take statins. According to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, positron emission tomography (PET) scans of lipophilic statin users revealed a highly significant decline in metabolism in the area of the brain that is first impacted by Alzheimer’s disease.

Statins are medications used to lower cholesterol and reduce the risk of heart attack or stroke. They are the most commonly used drugs in the developed world, and nearly 50 percent of Americans over age 75 use a statin. Different types of statins are available based on a patient’s health needs, including hydrophilic statins that focus on the liver and lipophilic statins that are distributed to tissues throughout the body.

Lipophilic statins include simvastatin, fluvastatin, pitavastatin, lovastatin and atorvastatin. Hydrophilic statins include rosuvastatin and pravastatin.

Attention Span Is Decreasing. How Social Media Affects Us

Exercise and supplements are both great, but if you are constantly feeding your system with home made stimulants that your body produces, you may be fighting an uphill battle. I experienced just that recently, I seemed to be forever on one social media platform or another constantly, under the excuse of promoting my videos, and it really took its toll. So, I just had a few weeks off, reading, exercising, relaxing outside, when the sun was out that is, and going for walks in nature…and now it is your turn. In Attention Span Is Decreasing, I look at how our modern lifestyles, with all their trappings and perks, can have the opposite effect to the one we are after, and how you can start to take back control. Mute alerts, use the flight mode, stick it in a drawer and embrace the 20−5−3 rule, to live not just longer, but happier, and healthier, both in body and mind, because they are inextricably linked. And if you want to know it all in a bit more depth, check out this video on my channel.


In Attention Span Is Decreasing, we will learn how our modern lifestyles, with all their trappings and perks, can have the opposite effect to the one we are…

Robot Doctors to Provide Health Care Services Soon

Still the comic relief til about December 31, 2024. By 2035 curing everything, already in the early stages towards that.


Giovanni Traverso, an MIT assistant professor of mechanical engineering, a gastroenterologist at Brigham and Women’s Hospital, and also the senior author of the study said, that they were actively working on robots that can help provide health care services to maximize the safety, of both the patients and the health care workforce.

Traverso and his colleagues after the Covid-19 began last year, worked towards reducing interaction between the patients and the health care workers. In this process, they collaborated with Boston Dynamics in creating mobile robots that can interact with patients who waited in the emergency department.

But the question here is, how patients are going to respond to the robots? This question was raised by the researchers of MIT along with Brigham and Women’s Hospital. The researchers conducted a nationwide large-scale online survey of about 1000 people working with a market research company called YouGov. The questions were about the acceptability of robots in healthcare for performing tasks like nasal swabs, inserting a catheter, and turning a patient over in bed.

Study shows potential dangers of sweeteners

Saccharine, aspartame, sucralose.


New research has discovered that common artificial sweeteners can cause previously healthy gut bacteria to become diseased and invade the gut wall, potentially leading to serious health issues.

The study, published in the International Journal of Molecular Sciences, is the first to show the of some of the most widely used artificial sweeteners—saccharin, sucralose, and aspartame—on two types of gut bacteria, E. coli (Escherichia coli) and E. faecalis (Enterococcus faecalis).

Previous studies have shown that artificial sweeteners can change the number and type of bacteria in the gut, but this new molecular research, led by academics from Anglia Ruskin University (ARU), has demonstrated that sweeteners can also make the bacteria pathogenic. It found that these can attach themselves to, invade, and kill Caco-2 cells, which are that line the wall of the intestine.

Telehealth Extends Coverage of High-Risk Maternal-Fetal Care

The U.S. is facing an unprecedented shortage of obstetricians and gynecologists (OB/GYNs). According to the American College of Obstetricians and Gynecologists, around half of the nation’s counties don’t have access to even a single OB/GYN, which means more than 10 million women are in need of OB/GYNs for primary care. Alarmingly, there are now 8000 fewer women’s health specialists than needed, and that number is predicted rise to 22000 by mid-century.


As the nation’s largest group of Maternal-Fetal Medicine (MFM) and OB/GYN Hospitalist providers, Obstetrix Medical Group is uniquely addressing this critical issue. With multiple diverse TeleMFM programs around the country, Obstetrix provides a key solution for hospitals and community OB/GYN physicians that improves access to specialty care for women with high-risk pregnancies.

Mednax clinicians have long relied on the benefits of telehealth to complement traditional in-person care. MFM providers specifically have utilized various forms of telehealth since the late 1980s. Today, virtual care continues to play an essential role in bridging distance gaps and bringing the highest quality care to patients in need, no matter their location. Through the use Vsee, one of Mednax’s primary telehealth platform vendors, as well as others, clinicians across the country are finding a silver lining during the COVID-19 pandemic. Though helpful in any region, in the rural areas of the Mountain West, it has become even more of a blessing. We spoke with Oliver (Bill) Jones, M.D., about how telehealth integrated into their practice and how it has positively impacted their high-risk patients.

A need for change

Obstetrix Medical Group of Colorado has been practicing for over thirty years and provides outreach to Colorado, Wyoming and Nebraska— a geography that requires long travel time for either physicians or patients. Although they have been in practice for a while, using telehealth to care for patients has accelerated in use for most members of their group. Dr. Jones explains that their team flew across states to meet with their patients before the pandemic, making for very long days. In addition, the unpredictable Colorado weather sometimes affected the flight’s departures and return times. Dr. Jones laughs, remembering a particularly nasty snowstorm back in November of 2019 that jumpstarted the conversations about telehealth. The flight to Casper, Wyo., was cancelled but Dr. Jones did not want the patients to have to reschedule appointments. He worked with the sonographer to come up with an alternative solution of virtual visits.

Google deepens its healthcare presence: A timeline of the last year

Google has invested heavily in healthcare. I think in the end, they will be the ultimate profile provider for users. Just connect your electronic health record with your personal profile combined with Fitbit wearable technologies.


Google has made moves to expand its presence in the healthcare sector during the last 12 months, including multiple partnerships with health systems, several new product launches and efforts to facilitate the country’s COVID-19 vaccine rollout.

Below is a timeline of Google’s key healthcare moves reported by Becker’s Hospital Review since June 2020.

June 18, 2020: Google sister company Verily developed a program to help employees and students safely return to offices and shared spaces while monitoring for COVID-19. The program, dubbed Healthy at Work, is powered by Verily’s software and COVID-19 testing infrastructure.

Microglia-mediated inflammation of the amygdala in autism

According to a new study1, an anti-inflammatory protein called interleukin-38, or IL-38, is decreased in the brains of people with autism.

To help protect the brain from injury and infection, the immune cells in the brain, called microglia, usually produce inflammatory molecules2. But it is a tough balance – an inappropriate, or too large, inflammatory response can harm the health of the brain.

Research has shown that there may be changes in the structure and function of microglia in the brains of people with autism. This suggests that atypical inflammatory responses may play a role in autism3, 4, 5.

Where Will You Go When a Robot Takes Your Job?

Smart strategies like this can help workers learn to embrace technological change. If the government helps people plan their next move if and when they’re no longer needed in their current job, workers will be able to roll with the economy’s punches more easily. Combined with national health insurance, education and retraining assistance — and a robust unemployment insurance system — it could make terror of job loss a thing of the past.


The U.S. government must assuage people’s anxiety about technology upending their working lives, in part by helping them forge new career paths.

An ally for alloys: AI helps design high-performance steels

Machine learning techniques have contributed to progress in science and technology fields ranging from health care to high-energy physics. Now, machine learning is poised to help accelerate the development of stronger alloys, particularly stainless steels, for America’s thermal power generation fleet. Stronger materials are key to producing energy efficiently, resulting in economic and decarbonization benefits.

“The use of ultra-high-strength steels in power plants dates back to the 1950s and has benefited from gradual improvements in the materials over time,” says Osman Mamun, a postdoctoral research associate at Pacific Northwest National Laboratory (PNNL). “If we can find ways to speed up improvements or create new materials, we could see enhanced efficiency in plants that also reduces the amount of carbon emitted into the atmosphere.”

Mamun is the lead author on two recent, related journal articles that reveal new strategies for machine learning’s application in the design of advanced alloys. The articles chronicle the research outcomes of a joint effort between PNNL and the National Energy Technology Laboratory (NETL). In addition to Mamun, the research team included PNNL’s Arun Sathanur and Ram Devanathan and NETL’s Madison Wenzlick and Jeff Hawk.

Rates of Parkinson’s disease are exploding. A common chemical may be to blame

Most cases of Parkinson’s disease are considered idiopathic – they lack a clear cause. Yet researchers increasingly believe that one factor is environmental exposure to trichloroethylene (TCE), a chemical compound used in industrial degreasing, dry-cleaning and household products such as some shoe polishes and carpet cleaners.

To date, the clearest evidence around the risk of TCE to human health is derived from workers who are exposed to the chemical in the work-place. A 2008 peer-reviewed study in the Annals of Neurology, for example, found that TCE is “a risk factor for parkinsonism.” And a 2011 study echoed those results, finding “a six-fold increase in the risk of developing Parkinson’s in individuals exposed in the workplace to trichloroethylene (TCE).”

Dr Samuel Goldman of The Parkinson’s Institute in Sunnyvale, California, who co-led the study, which appeared in the Annals of Neurology journal, wrote: “Our study confirms that common environmental contaminants may increase the risk of developing Parkinson’s, which has considerable public health implications.” It was off the back of studies like these that the US Department of Labor issued a guidance on TCE, saying: “The Board recommends […] exposures to carbon disulfide (CS2) and trichloroethylene (TCE) be presumed to cause, contribute, or aggravate Parkinsonism.”

/* */